Sensitization from transfusion in patients awaiting primary kidney transplant. - Wikidata - wikimedia - TriplyDB

Sensitization from transfusion in patients awaiting primary kidney transplant.

Sensitization from transfusion in patients awaiting primary kidney transplant.

http://www.wikidata.org/entity/Q37262842

about

Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).HLA sensitisation: can it be prevented?Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.Should target hemoglobin levels in dialysis patients be lowered to 9-10 g/dl?Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease.Leukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease.Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications.Clinical pancreatic islet transplantation.Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.ESRD Payment Reform: First Do No Harm.ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption.Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events.The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.Anemia in chronic kidney disease.

P2860

Q34857944-9EB0D605-3D16-411C-88A5-5539A7550FF6 Q35097898-5A006ED0-B436-4E64-9D16-45B308C71279 Q35811966-09BCC7D0-1795-4B1A-8D58-EC095D05C4B3 Q38199174-1CFB0415-19FB-4FC1-BFE4-5A9D9A845932 Q38436060-F9517456-6297-4406-81E0-50CF63D91085 Q38844594-1807D76F-B73D-477E-B960-0B0D102CC266 Q38900551-F83712C5-2B8A-4B96-A99C-225028072758 Q39005220-046631B7-31CB-4B4E-B172-96F792B74000 Q40452726-7F134733-02CD-4DF5-8556-6FF06D3EA0A5 Q42389549-D0B47E1D-7616-4087-94A7-DC64FB64133F Q43713630-25249636-241E-4AA3-B84F-C549EF75A513 Q47167963-C1E5D2AE-972F-4A28-A755-B2AC193C0B26 Q50042370-A194D0FD-6BCD-4F15-BA04-F7509B1AB364 Q52665595-05D59042-9844-42D4-9011-1B05C73D810A Q53078854-81419E6E-7859-46E0-9655-BFC296241232 Q53354670-29B15802-831F-45A4-A809-8AC1227101CD

P2860

Sensitization from transfusion in patients awaiting primary kidney transplant.

http://www.wikidata.org/entity/Q37262842

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sensitization from transfusion in patients awaiting primary kidney transplant.

@en

Sensitization from transfusion in patients awaiting primary kidney transplant.

@nl

type

label

Sensitization from transfusion in patients awaiting primary kidney transplant.

@en

Sensitization from transfusion in patients awaiting primary kidney transplant.

@nl

prefLabel

Sensitization from transfusion in patients awaiting primary kidney transplant.

@en

Sensitization from transfusion in patients awaiting primary kidney transplant.

@nl

P1433

Q37262842-E6D44C91-3802-4B82-AF01-1B8865CE2277

P1476

Q37262842-995461B7-CD65-40FC-ABC5-32269D175C57

P2093

Q37262842-16422938-17A8-4DFD-B8B7-576DE8B697F8

Q37262842-3D9B5C34-481B-4810-AC80-DAEF8924E3D3

Q37262842-55D5E558-E1B4-42B0-B61B-F1103B238FC3

Q37262842-638D6883-049B-4939-B025-67E4CB540E46

Q37262842-64D1F7D1-AB1D-4CBC-A8D4-7C8CDFFECF49

Q37262842-8BFB4F08-9D34-40EF-8355-9447F1D62027

Q37262842-8D4BB75B-46BA-466A-A8C5-A77D28C1B28B

Q37262842-EC075931-47FD-47B3-99AF-F7A4C86FFD27

Q37262842-F3892EF3-1263-4904-8B3B-8D2F2CC115F9

P2860

Q37262842-008EA35C-0B54-4B32-94B9-243C03EC5F1D

Q37262842-135FECF6-2AAC-4237-91A3-CF2A3DEC782B

Q37262842-3DF6790C-E15A-48A5-8C20-5294C764A894

Q37262842-4D80116D-6FBA-4379-9BAB-B8D92635BCDF

Q37262842-52EC7904-7783-4F10-867A-B9C138C5CE4F

Q37262842-549782EC-ABE2-4C4B-9F1B-A5043BFAC3DE

Q37262842-5EDE5B30-83C6-4D37-852F-644CDBCAF284

Q37262842-60D88661-8640-4B2D-A3C9-599BD746A774

Q37262842-62C229F1-00B3-4638-AD3A-852EC449FC15

Q37262842-67337978-02AA-40B3-874A-703CB3013982

P304

Q37262842-25492F30-D711-422F-A077-1DB0DCFBA7C1

P31

Q37262842-6FE1849E-6649-44F6-9E00-BA2B538DE9AB

P356

Q37262842-7EE9D017-EADD-485C-B8A5-ECB84FC1B0AA

P407

Q37262842-7298BA1A-577D-4307-9E07-DE4F262E4ED1

P433

Q37262842-BB3F384E-600C-46D6-AEE5-1AC2C61757EF

P478

Q37262842-A69B5B4C-9EBD-4CBD-AA3F-6E391A80D62A

P577

Q37262842-6A002D21-70A8-40B3-B7EF-F5FD889BA958

P5875

Q37262842-F5D4F535-8430-4258-B515-14630D4D609D

P698

Q37262842-615B5F0A-93BC-4226-8792-3DDFC2587119

P932

Q37262842-ED2600E4-346D-411D-AAEE-96A6BB2CCD00

P356

P1433

Nephrology Dialysis Transplantation

P1476

Sensitization from transfusion in patients awaiting primary kidney transplant.

@en

P2093

Brian D Bradbury

http://www.w3.org/2001/XMLSchema#string

Calvin D Lou

http://www.w3.org/2001/XMLSchema#string

Deborah Kim

http://www.w3.org/2001/XMLSchema#string

Dolly B Tyan

http://www.w3.org/2001/XMLSchema#string

Glenn M Chertow

http://www.w3.org/2001/XMLSchema#string

Jeffrey Petersen

http://www.w3.org/2001/XMLSchema#string

Jerome Rossert

http://www.w3.org/2001/XMLSchema#string

Julie M Yabu

http://www.w3.org/2001/XMLSchema#string

Matthew W Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Identifying persons with diabetes using Medicare claims data.

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.

Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

Emerging infectious disease agents and their potential threat to transfusion safety.

Transfusion risks and transfusion-related pro-inflammatory responses.

Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.

Calculated PRA (CPRA): the new measure of sensitization for transplant candidates.

P304

2908-2918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFT362

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256452435

http://www.w3.org/2001/XMLSchema#string

P698

24009295

http://www.w3.org/2001/XMLSchema#string

P932

3811060

http://www.w3.org/2001/XMLSchema#string